ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
1,04%
Bitcoin
63.048,47
0,00%
Brent Oil
83,95
0,47%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aditxt Inc (ADTX)

  7. Aditxt Inc (ADTX) Notícias

ADTX

Aditxt (ADTX)

Aditxt Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADTX
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
03/05/202415:14Business WireCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
03/05/202410:00Business WireAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
02/04/202409:30Business WireAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)NASDAQ:ADTXAditxt Inc
27/03/202409:36PR Newswire (US)Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023NASDAQ:ADTXAditxt Inc
07/03/202409:54PR Newswire (US)For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyNASDAQ:ADTXAditxt Inc
04/03/202419:27Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
22/02/202419:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
14/02/202411:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADTXAditxt Inc
01/02/202410:00PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023NASDAQ:ADTXAditxt Inc
30/01/202410:30Business WireAditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology ApplicationsNASDAQ:ADTXAditxt Inc
23/01/202418:18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADTXAditxt Inc
18/01/202418:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADTXAditxt Inc
08/01/202410:30Business WireAditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 MillionNASDAQ:ADTXAditxt Inc
05/01/202410:30Business WireAditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
02/01/202410:30Business WireAditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:ADTXAditxt Inc
29/12/202319:07Business WireAditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
12/12/202310:30Business WireAditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women GloballyNASDAQ:ADTXAditxt Inc
16/11/202318:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADTXAditxt Inc
16/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADTXAditxt Inc
13/11/202318:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADTXAditxt Inc
09/11/202320:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADTXAditxt Inc
06/10/202309:00GlobeNewswire Inc.Aditxt, Inc. to Present at 8th Annual Dawson James ConferenceNASDAQ:ADTXAditxt Inc
05/10/202309:00Business WireAditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me PlatformNASDAQ:ADTXAditxt Inc
22/09/202311:19Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ADTXAditxt Inc
21/09/202310:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ADTXAditxt Inc
08/09/202308:05Business WireAditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023NASDAQ:ADTXAditxt Inc
06/09/202317:30Business WireAditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
31/08/202320:00Business WireAditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
18/08/202308:02Business WireAditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial ScaleNASDAQ:ADTXAditxt Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADTX

Seu Histórico Recente

BOV
BBAS3
BANCO DO BRASIL ON
BOV
PETR3
PETROBRAS ON
NYSE
PBR.A
Petroleo Brasileiro ADR
COIN
LTCUSD
Litecoin
COIN
XMRUSD
Monero
BOV
VALE3
VALE ON
EU
PX1
CAC 40
COIN
BCHBTC
Bitcoin Cash
BOV
ITSA4
ITAUSA PN
BOV
IBOV
Índice Bovespa
NYSE
GGB
Gerdau
COIN
ADABTC
Cardano
BOV
GFSA3
GAFISA ON
COIN
XRPBTC
Ripple
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados